Tandem Diabetes Care (TNDM) Q4 Earnings on the Horizon: Analysts' Insights on Key Performance Measures

Core Insights - Tandem Diabetes Care, Inc. (TNDM) is expected to report a quarterly loss of $0.25 per share, reflecting a 7.4% increase compared to the same period last year. Revenue is forecasted at $255.18 million, indicating a year-over-year increase of 29.7% [1] Financial Projections - Analysts estimate 'Sales- Pump- United States' to be $101.47 million, representing a 23.2% increase from the previous year [4] - 'Sales- Supplies and Other- United States' is projected at $89.43 million, showing a 10.3% increase year over year [4] - 'Geographic Sales- Outside the United States' is expected to reach $59.87 million, indicating a 30.5% year-over-year change [5] - 'Geographic Sales- United States' is forecasted at $190.90 million, reflecting a 26.5% increase from the prior year [5] - 'Sales- Supplies and Other- Outside the United States' is estimated at $40.50 million, suggesting a 10% year-over-year increase [6] - 'Sales- Pump- Outside the United States' is projected to be $19.85 million, indicating a 13.3% increase year over year [6] Market Performance - Shares of Tandem Diabetes Care have declined by 10.7% over the past month, while the Zacks S&P 500 composite has decreased by 1.8% [7] - TNDM holds a Zacks Rank of 3 (Hold), suggesting it is expected to perform in line with the overall market in the near future [7]